Journal article icon

Journal article

Neuropsychiatric adverse effects of mefloquine - What do we know and what should we do?

Abstract:

Malaria is still one of the most important tropical diseases, killing millions every year. The number of effective drugs is limited, because of the ability of the causative parasite Plasmodium falciparum to develop drug resistance. Mefloquine, if possible in combination with an artemisinin derivative, is the only efficacious treatment left for uncomplicated but highly multidrug-resistant P. falciparum infections encountered in some areas. Mefloquine remains effective in most endemic areas wor...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Journal:
CNS DRUGS
Volume:
11
Issue:
1
Pages:
1-8
Publication date:
1999-01-05
DOI:
ISSN:
1172-7047
URN:
uuid:6e7fe344-0740-43ec-b2d8-ca70c4f8a25d
Source identifiers:
19992
Local pid:
pubs:19992
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP